MAXIMUS DIAGNOSTIC TECH LLC has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), Canada and United States. Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are BOSTON HEART FOUNDATION INC, EXPERIMENTAL RES CENTER CHINA ACADEMY OF CHINESE MEDICAL SCIENCES and THORNER MICHAEL O.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Canada | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | China | 1 | |
#6 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Medical preparations | |
#5 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Liu Julia J | 7 |
#2 | Davis Elisabeth Melika | 3 |
#3 | Liu Julia | 3 |
#4 | Davis Elisabeth | 2 |
#5 | Irvin Randall Thomas | 1 |
Publication | Filing date | Title |
---|---|---|
CN110418668A | The method for identifying intestines leakage syndrome | |
WO2017136511A1 | Assessment of intestinal barrier function to improve treatment of inflammatory bowel disease | |
EP2893032A1 | Methods and composition for detecting intestinal cell-barrier dysfunction |